Noninvasive measurement of arterial oxygen saturation (Sa02) by pulse oximetry is widely acknowledged to be one of the most important technological advances in monitoring clinical patients. Pulse oximeters compute Sa02 by measuring differences in the visible and near infrared absorbances of fully oxygenated and deoxygenated arterial blood. Unlike clinical blood gas analyzers, which require a sample of blood from the patient and can provide only intermittent measurement of patient oxygenation, pulse oximeters provide continuous, safe, and instantaneous measurement of blood oxygenation. 
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Noninvasive measurement of arterial oxygen saturation (Sa02) by pulse oximetry is widely acknowledged to be one of the most important technological advances in monitoring clinical patients. Pulse oximeters compute Sa02 by measuring differences in the visible and near infrared absorbances of fully oxygenated and deoxygenated arterial blood. Unlike clinical blood gas analyzers, which require a sample of blood from the patient and can provide only intermittent measurement of patient oxygenation, pulse oximeters provide continuous, safe, and instantaneous measurement of blood oxygenation. Here I review the theoretical background behind this advanced technology, instrumentation requirements, practical instrument calibration, common features of commercial pulse oximeters, specific clinical applications, and performance limitations of pulse oximeters.
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Accurate assessment of blood gases is fundamental to the support of critical-care medicine. Various diagnostic measurements are available to assist the clinician in determining a patient's oxygenation status and to protect the patient against dangerous hypoxic conditions. Traditionally, blood gases have been measured by invasive sampling, either through an indwelling arterial catheter or by arterial puncture, and analyzed in a clinical laboratory by a blood gas analyzer. Although central clinical "8tat" laboratories can provide accurate measurements of multiple respiratory and metabolic variables from small blood samples, this practice presents significant drawbacks-mainly the prolonged delay between sample acquisition and the availability of the laboratory results. In neonatal applications, for example, frequent blood sampling can cause significant blood loss, especially for very small infants, unless microblood samples are used for analysis. Furthermore, blood gas values are available only intermittently and, therefore, indicate the status of the patient only at the time the blood sample was drawn. The inevitable delay and lack of continuous information can lead to potential diagnostic errors Various optical methods for measuring oxygen saturation have been developed, based on light transmission through, or reflection from, tissue and blood at two specific wavelengths: A,, where there is a large difference in light absorbance between Hb and Hb02 (e.g., 660 nm), and A2, which can be an isobestic wavelength (e.g., 805 nm), where the absorbance of light is independent of blood oxygenation, or a different wavelength in the near infrared region >805 nm, where the absorbance of Hb is slightly smaller than that of Hb02.
The absorbance of light at a specific wavelength by a homogeneous solution can be accurately determined by using Beer-Lambert's law, which can be written as p0. acd where P, is the transmitted light power, P0 is the incident light power, a is the specific absorptivity or molar absorptivity of the sample, c is the concentration of the sample, and d is the pathlength of the light.
Assuming for simplicity that a thoroughly hemolyzed blood sample consists of a two-component homogeneous mixture (e.g., Hb and Hb02) and that light absorbance by the mixture of these two components is additive, the following relationship can be derived: After the initial light transmission through the bloodless ear was measured and a baseline value was established, the pressure in the capsule was released and a second measurement was taken through the uncompressed ear. Sa02 was then determined, based on the difference in these two measurements.
Although this approach was the first significant step towards an accurate noninvasive measurement of Sa02, it was not very successful, mainly because of problems associated with the calibration of the ear probe, inaccuracy, and lack of reproducibility.
The first widely used commercial ear oximeter was developed by the Hewlett-Packard (H-P) Company in the early 1970s (6). Briefly, a high-intensity tungsten lamp was used to generate a broad spectrum of light. Eight narrow-band optical interference filters were mounted on a rotating wheel that intercepted the light path sequentially and provided a source of wavelength selection. These filtered light-beam pulses entered a fiber optic cable that carried the pulses to the ear. A second fiber optic cable carried the light pulses that were transmitted through the ear back to the instrument for detection and analysis. To measure oxygen saturation, one attached the ear probe to the pinna of the ear after rubbing the ear briskly for -20 s to increase local blood flow. After the ear probe was properly positioned on the ear, a temperature-controlled heater within the ear probe maintained the temperature of the probe and nearby ear tissue at 41 #{176}C, causing an increase in local blood flow by proper blood "arterialization."
The H-P ear oximeter measured
Sa02 by comparing the intensity of light passing through the ear at eight Figure 3 . At -85% SaO2, the amount of light absorbed by the Hb and the Hb02 is about the same. Hence the normalized amplitudes of the red and infrared signals are equal (i.e., R/LR = 1.0). Because the optical properties of blood are fairly similar among different individuals, no individual instrument calibration is required in the field.
Absorption due to tissue
The major advantage of this photoplethysmographicbased approach is that only two wavelengths are required to determine Sa02. This greatly simplifies the configuration of the optical sensor. Furthermore, blood "arterialization," which was essential in the earlier H-P ear oximeter, is no longer necessary, thus eliminating the need for continuous skin heating.
Pulse Oximeter Sensors
The sensor of the original pulse oximeter as described by Yoshiya et al. (8) was based on a bulky fiber optic cable. The fiber optic cable in this implementation was used only as a guide to conduct light from a quartz halogen lamp to the remote measurement site and to conduct the light transmitted through the tissue back to the photodetector. The light source and the photodetector were both housed inside the oximeter. Narrowbandpass interference optical filters were used in combination with a mechanical chopper to properly select the red and infrared wavelengths and to synchronize the detection of the transmitted light with the measurements made by the photodetector.
An improved design of a noninvasive pulse oximeter sensor was introduced in the United States in the early (Figure 4A ) relies on the time average of the peak-to-peak amplitudes of each pulse. This approach is relatively slow, because it depends on the patient's heart rate sothat raw signals are available for averaging only once every heartbeat.
An alternative approach ( Figure 4B ) is to average many step changes along the steep slopesof the photoplethysmogram. This approach results in many more data points between successiveheartbeats, so that the instrument response time is much shorter. In addition, the accuracy and stability of the measured saturation values displayed by the oximeter are usually enhanced in the latter ap-
proach.
Numerous studies have evaluated and compared the accuracy of different pulse oximeters over a wide range of clinical conditions (9-15). Generally, the accuracy of most noninvasive pulse oximeters is acceptable for a wide range of clinical applications. Most manufacturers claim that their instruments are accurate to within ±2% in the Sa02 range between 70% and 100% and ±3% for saturations between 50% and 69%. Besides Sa02, most pulse oximeters also offer other display features, including pulse rate and analog or bar graph displays to indicate pulse waveform and relative pulse amplitude. These important features allow the user to assess in real time the quality and reliability of the measurement. For example, the shape and stability of the photoplethysmographic waveform can be used as an indication of possible motion artifacts or low perfizsion conditions. Similarly, if the patient's heart rate displayed by the pulse oximeter differs considerably from the actual heart rate, the displayed saturation value should be questioned.
In addition to pulse oximetry, some manufacturers of medical instrumentation have incorporated into their patient monitoring products other physiological monitors such as temperature, electrocardiography, blood pressure, end tidal CO2 (capnography), and most recently also the concentrations of various anesthetic agents.
Sensor Attachment
Several locations on the body-e.g., ear lobes, fingertips, and toes-are suitable for monitoring Sa02 with trmission pulse oximeter sensors. The most popular sites are the fingertips: the location is convenient and a good photoplethysmographic signal can be obtained quickly.
Other locations on the skin that are not accessible to conventional transillumination techniques can be monitored by using a reflection (backscatter) 5a02 sensor. Reflection sensors are usually attached to the forehead or temples with double-sided adhesive tape. A headband can be used to hold the sensor in place and to minimize interference from ambient light. Low peripheral vascular perf usion. Because pulse oximeters rely on adequate arterial pulsation, a significant decrease in peripheral vascular pulsation-such as in hypotension, vasoconstriction, or hypothermia or during cardiopulmonary bypass or cardiac arrest,-can produce a signal too small to be processed reliably by the oximeter. Locally applied vasodilating drugs could be useful to enhance the pulsatile signal in certain situations. In general, pulse oximeters become more susceptible to motion artifacts under low-perfusion conditions. When the oximeter cannot detect adequate pulsatile signals, it usually displays a "Low Perfusion" or similar message to alert the user of possible problems in peripheral blood perfusion.
Practical LImitatIons of Pulse
Another potential problem with pulse oximeter measurements is venous congestion, which leads to artifacts due to venous pulsation. Because the measurement relies on a pulsatile signal, some of the pulse may actually contain venous blood of lower oxygen content mixed with higher oxygen content in the arterial blood.
Motion arti/hcts. Pulse oximeters detect a pulsatile signal that normally is only a small percentage of the total photoplethysmographic signal.
Therefore, any transient motion of the sensor relative to the skin can cause a significant artifact in the optical measurement.
Furthermore, if these transient artifacts mimic a heartbeat, the instrument may be unable to differentiate between the pulsations that are due to motion artifacts and the normal arterial pulsations, thereby causing erroneous readings. Practically, these artifacts can be reduced by digital signal processing and averaging the Sa02 values over several seconds before they are displayed. Motion artifacts, such as during shivering or seizure activity, are usually recognized by false or erratic heart-rate displays or by distorted photoplethysmographic waveforms.
Some manufacturers use the R-wave of the patient's electrocardiogram to synchronize the optical measurements; they thereby improve the detection of noisy pulsatile signals by enhancing the signal-to-noise ratio of the measurements through the use of multiple timeaveraged signals.
Effect of fetal hemoglobin. At birth, fetal hemoglobin constitutes 60-95% of the total hemoglobin in the erythrocytes of both preterm and term newborns. Therefore, one of the concerns clinicians may have is related to the interpretation of pulse oximeter readings in newborns, given that pulse oximeters are calibrated for adult patients. However, several studies (16-18) have shown that the difference in the optical absorbanceof adult and fetal hemoglobins is too small (<3%) to affect the clinical accuracy of pulse oximetry measurements.
Interference by electrical energy and stray light. The readings of pulse oximeters may be affected by highfrequency radio interference from electrocautery units and high-intensity light sources such as infrared, xenon, and fluorescent lamps (19-21) . Some manufacturers of pulse oximeters try to minimie the effect of stray light by taking intermittent optical background readings when both of the LEDs in the sensor are turned off and then subtracting these readings from measurements taken by the photodetector when either the red or infrared LED is turned on. By sequencing the LEDs at a switching frequency that is an integer multiple of the power line frequency, the effect of room light flickering from fluorescent light sources can be greatly reduced. Furthermore, wrapping the sensor with a dark material is also helpful in reducing interference from stray light. and excessproduction of methemoglobin can cause an increase in the amount of methemoglobin in the blood. Therefore, erroneous pulse oximeter readings can result.
On the other hand, carbon monoxide, a normal product of hemoglobin catabolism in the body, readily competes with hemoglobin for oxygen-binding sites and has optical absorbance characteristics similar to HbO. The proportion of HbCO in the blood of normal subjects is typically <2%. In smokers or smoke-inhalation victims, however, the proportion of HbCO may rise to >10%. Clinical studies show that increased proportions of HbCO will lead to overestimation of 5a02 by a pulse oximeter (22,23).
When comparing pulse oximeter readings with results by standard CO oximetry, one must be aware of the difference between these two measurements.
For example, the 1L282 CO-Oximeter, a dedicated spectrophotometer widely used as a reference for calibrating pulse oximeters, operates with use of four different wavelengths; therefore, it can measure total hemoglobin, Hb02, HbCO, and methemoglobin, and express each as a percentage of the total hemoglobin in a given sample of blood. The value reported by a CO-Oximeter is commonly termed fractional HbO2 and is equal to the amount of HbO2 expressed as a fraction of the amount of total hemoglobin, i.e., the total of all active and inactive forms of hemoglobin with respect to the oxygen-binding capability. In contrast, pulse oximeters use only two wavelengths and, therefore, cannot distinguish between the relative concentration of each type of hemoglobin derivative present in the blood. Therefore, a pulse oximeter measures the relative concentration of Hb02, expressed as a fraction of the total amount of hemoglobin able to bind oxygen, namely, the ratio (expressed as a percent fraction) between the concentration of Hb02 and the concentrations of Hb02 and deoxyhemoglobin (Hb) (24) (25) (26) (27) .
Intravenous dyes introduced
into the blood can also cause inaccurate Sa02 readings (28-30) . Of the dyes considered in the above three references, methylene blue, which is commonly used to treat above-normal concentrations of methemoglobin, has the strongest effect on pulse oximeters, causing spuriously low Sa02 values. This effect is due to the large absorbance peak of this dye around 670 nm, close to the 660-nm wavelength used in most pulse oximeters.
Recognizing 
Applications of Pulse Oxlmetry
Pulse oximetry is widely used in various clinical applications, including during anesthesia, surgery, critical care, hypoxemia screening, exercise, and transport from the operating room to the recovery room and in the emergency room and in the field (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) .
The availability of small, lightweight optical sensors makes Sa02 monitoring especially applicable for preterm neonates and pediatric and ambulatory patients. In many applications, pulse oximetry has replaced transcutaneous oxygen tension monitoring in neonatal intensive care. In infants, however, the main utility of pulse oximeters, especially during the administration of supplemental oxygen, is in preventing hypoxia, not hyperoxia. Although high concentrations of oxygen in premature neonates are associated with increased risk of retrolental fibroplasia, the Hb02 dissociation curve is flattened at saturation values >90-95%, and errors of only a few percent in 5a02 measurements could easily represent a large and significant error in the oxygen tension value. Therefore, pulse oximeters are not accurate enough to safeguard against hyperoxia in neonates at risk of retrolental fibroplasia.
Pulse oximetry has been suggested as a home monitor for apnea in infants and children at risk for sudden infant death syndrome and for the adequacy of oxygen therapy in chronic respiratory patients. However, the expense and the frequent false alarms caused by motion artifacts limit the wide use of pulse oximeters for these specific applications.
Despite a decade of significant technological progress, the scope of pulse oximetry is still expanding. Improvements in performance continue to be made as new algorithms are being developed to reduce the occurrence of motion artifacts.
Although pulse oximeters are valuable tools, there is at present no way for a user to test whether a pulse oximeter is accurate. Manufacturers of pulse oximeters sometimes provide simple electronic simulators to test the major functions of their oximeters. These simulators, which plug directly into the sensor input of the oximeter, can be used to test the electronic Anesthesiologists. In 1988, the Society for Critical Care Medicine recommended that pulse oximetry be used to monitor patients undergoing oxygen therapy. The mandatory or voluntary use of pulse oximeters by several other professional and regulatory agencies is likely to continue.
The increasing cost of health care today makes the use of noninvasive pulse oximetry even more attractive because it allows effective oxygen monitoring without the time, risk, and high cost associated with clinical laboratory analysis of blood samples. In an era of cost containment and sophisticated medical technology, future generations of diagnostic medical devices will surely provide the ability to continuously and noninvasively monitor not only oxygen saturation but also other important metabolic variables in the body.
